We just need your registered Email Id
to sent your password reset
instructions.
You're doing something extraordinary. We'll keep you in the loop with our latest news and special offers. Please update your profile on a regular basis and be an active community member. Let others know we exist and together we can move medicine forward.
You are now registered within Modern Trials network. If we receive patient inquires within your zip code we will let you know. Be on the look out for an E-Mail from our team.
| NCT Id | NCT04833959 |
|---|---|
| Title | Pilot Study of 89-Zr Panitumumab in Pancreas Cancer |
| Condition | Pancreas Cancer |
| StudyType | Interventional |
| Organization | Stanford University |
| Sponsor/Collaborators | Stanford University |
| Status | Recruiting |
| Gender | All |
| AgeGroup | Adult Older Adult |
| Location (with distance) |
|
| Description | The main purpose of the study is to assess the safety of 89Zr-panitumumab as a molecular imaging agent in patients with (metastatic) pancreas cancer. |
Your interest has been recorded and our team is working hard for you. We will contact you with further steps.